- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
72 Cards in this Set
- Front
- Back
|
Anemias due to increased destruction of red cells
|
Hemolytic anemias
|
|
is associated with a release of hemoglobin and lactic acid dehydrogenase (LDH).
|
Hemolysis
|
|
Hemolysis may be either?
|
Intravascular or Extravascular
|
|
RBCs lyse in the circulation releasing hemoglobin into the plasma.
Causes include mechanical trauma, complement fixation, and other toxic damage to the RBC. The fragmented RBCs are called schistocytes. |
Intravascular hemolysis
|
|
RBCs are phagocytized by macrophages in the spleen and liver.
Causes include RBC membrane abnormalities such as bound immunoglobulin, or physical abnormalities restricting RBC deformability that prevent egress from the spleen. This is characterized by spherocytes. |
Extravascular hemolysis
|
|
If onset of hemolysis is abrupt:
What are the signs/symptoms? |
Tachycardia and dyspnea
The anemia is severe |
|
Patients with underlying cardiovascular disease and severe uncompensated hemolysis
May present with: |
Angina
Heart failure symptoms Hemosiderosis, leg ulcers, folate deficiency, and gallstones can also occur. |
|
What are five main causes of hemolytic anemia?
|
Hereditary spherocytosis
G6PD deficiency Sickle cell anemia Acquired Hemolytic Anemias Immune Mediated Hemolysis |
|
is an autosomal dominant disease of variable severity
CHARACTERISTICS: Defective or absent spectrin molecule Leads to loss of RBC membrane, leading to spherocytosis Decreased deformability of cell Increased osmotic fragility Extravascular hemolysis in spleen |
Hereditary spherocytosis
|
|
Diagnosed during childhood
Anemia -may or may not be present (BM may compensate) Severe Anemia: Folate Deficiency BM impaired by infection (Parvovirus B19) Chronic hemolysis causes: jaundice Gallstones = cholecystitis Examination = icterus and a palpable spleen |
Signs and symptoms of hereditary spherocytosis
|
|
What are the laboratory findings with hereditary spherocytosis?
|
Hematocrit may be normal
Reticulocytosis is always present The peripheral blood smear (PBS) *spherocytes *small cells that have lost their central pallor microcytosis increased MCHC May be an increase in indirect (unconjugated ) bilirubin The Coombs test is negative |
|
How do you TX hereditary spherocytosis?
|
Treatment with uninterrupted supplementation with folic acid, 1 mg/d.
The treatment of choice is splenectomy (will eliminate the site of hemolysis). In very mild cases discovered late in adult life, splenectomy may not be necessary. |
|
is the most common disease-producing enzymopathy in humans
Inherited as an X-linked disorder Affects 400 million people worldwide The disease is highly polymorphic, with more than 300 reported variants. It confers protection against malaria, which probably accounts for its high gene frequency. |
(G6PD) deficiency
|
|
is a housekeeping enzyme critical in the redox metabolism of all aerobic cells.
|
Glucose 6-phosphate dehydrogenase (G6PD)
|
|
G6PD regenerates?
|
NADPH (nicotinamide adenine dinucleotide phosphate), allowing regeneration of GSH (glutathione) defends the red cells against oxidative stress
|
|
leads to hemolysis during oxidative stress.
Causative agents: Infection Medications Fava beans Oxidative stress leads to Heinz body formation and extravascular hemolysis |
Lack of G6PD
|
|
The spleen pinches off the Heinz body and the overlying membrane, leaving a “bite cell” or “blister cell”
|
(G6PD) deficiency
|
|
This is associated with an abrupt fall in the hemoglobin concentration of 3 to 4 g/dL, and the peripheral blood smear reveals cell fragments, microspherocytes, and eccentrocytes or "bite" cells .
|
Heinz Bodies (G6PD) deficiency
|
|
The laboratory workup for (G6PD) deficiency includes the following:
|
Determine the level of anemia
Check bone marrow function by obtaining a CBC count with the reticulocyte count Measure the actual enzyme activity of G6PD rather than the amount of (G6PD) protein. Check the Indirect(unconjugated) Bilirubin Check the serum Haptoglobin levels – These serve as an index of hemolysis and will be decreased. |
|
a plasma protein whose only known function is to bind free hemoglobin.
The quantity of this is increased in certain chronic diseases and inflammatory disorders and is decreased or absent in hemolytic anemia. Normal adult findings range from 100 to 150 mg/dL |
Haptoglobin
|
|
What imaging studies may be useful in diagnosing G6PD deficiency?
|
Abdominal ultrasound may be useful in assessing for splenomegaly and gallstones in cases of (G6PD) deficiency.
|
|
How do you treat G6PD deficiency?
|
Identification and discontinuation of the precipitating agent is critical. Treat with oxygen and bed rest. Consultations: Consultations with the following specialists should be sought after - Hematologists, Geneticists.
|
|
Patients with (G6PD) deficiency should heed the following precautions:
Avoid: |
Broad beans: i.e., fava beans
Infections : viral hepatitis, pneumonia and typhoid fever. Avoid oxidant drugs such as the antimalarial drugs Avoid nitrofurantoin Avoid nalidixic acid, ciprofloxacin, niridazole, norfloxacin, methylene blue, chloramphenicol, phenazopyridine, and vitamin K analogues Avoid sulfonamides Avoid exposure to certain chemicals such as those in mothballs |
|
Infants with prolonged neonatal jaundice as a result of (G6PD) deficiency are?
|
placed under special lights (ie, bili lights) that alleviate jaundice.
|
|
Exchange transfusion may be necessary in cases of ?
|
severe neonatal jaundice or hemolytic anemia caused by favism.
|
|
One of the most common of the hemoglobinopathies is Hgb S. It is a qualitative hemoglobin disorder.
In this there is a point mutation in the ß-chain resulting in encoding of a valine instead of the normal glutamine. This results in abnormal ßs chains combining with normal a-chains to form the abnormal hemoglobin 'S' RBC’s take on sickled-shape when in presence of decreased O² tension |
Sickle Cell Anemia
|
|
Under low oxygen, Hgb becomes insoluble forming long polymers
This leads to membrane changes (“sickling”) and vasoocclusion Hemolytic anemia, not iron deficient RBC distortion, 10-20 day lifespan (significantly shortened) |
Sickle Cell Anemia
|
|
Deoxygenation of SS erythrocytes leads to intracellular hemoglobin polymerization, loss of deformability and changes in cell morphology.
|
Affects on red blood cells due to sickle cell anemia
|
|
What can be seen in the clinical presentation of sickle cell anemia?
|
Variable degrees of hemolysis
Intermittent episodes of vaso - occlusion Tissue ischemia Acute and chronic organ dysfunction |
|
VOC - is caused by abnormally shaped red blood cells resulting in acute and chronic organ dysfunction
VOC- sickled cells occlude capillaries and small blood vessels VOC - Obstructs blood flow causing tissue ischemia VOC - Reduces blood flow causing further tissue hypoxia VOC - Increased tissue hypoxia increases “sickling” |
Vaso Occlusion
|
|
can occur in any tissue, most commonly affect extremities, lower back and abdomen
Can occur in any tissue or organ Factors contributing to this include fever, hypoxia, dehydration, hypothermia, emotional stress or nothing |
Vaso Occlusion
|
|
Vaso-occlusive crisis lasting longer than 7days search for other causes of bone pain:
|
Osteomyelitis
Avascular necrosis Compression deformities When a recurrent bone crisis lasts for weeks, an exchange transfusion may be required to abort the cycle. |
|
What are three complications associated with sickle cell anemia?
|
Pain - difficult to manage with frequent recurrences
Increased risk of infection Acute Chest Syndrome |
|
How do you manage a sickle cell crisis?
|
Vasoocclusive crisis is treated with vigorous hydration and analgesics.
Intravenous fluids :to correct dehydration and to replace continuing loss. Normal saline and 5% dextrose in saline may be used. These fluids should be given intravenously, and treatment must be in an inpatient setting. |
|
What is the drug of choice for controlling pain in a sickle cell crisis?
|
Morphine
|
|
Chronic pain associated with sickle cell anemia is controlled how?
|
Chronic pain is managed with long-acting oral morphine preparations and acetaminophen and NSAIDs.
NSAIDs are effective in reducing deep bone pain. Patients may require breakthrough oral opiates also codeine and hydrocodone, are used first. |
|
Sudden trapping of blood within the spleen. Usually occurs in infants under 2 years of age.
May be associated with fever, pain, and respiratory symptoms. Circulatory collapse and death can occur in less than thirty minutes. |
Splenic Sequestion
|
|
This is one of the first complications in sickle cell syndromes with the highest incidence between
ages six months and two years. The sickle red cells cause painful swelling of the hands and feet. This is treated with fulids and pain medication. It usually will go away in a few days without any problems. |
Hand Foot Syndrome - Dactylitis
|
|
What are two other problems, apart from splenic sequestion and dactylitis, that are associated
with sickle cell anemia |
Leg ulcers and eye problems (vascular damage to the eye)
|
|
The risk of this is 400 x greater in SCD than in the general population
#1 cause of death infants and young children Functional asplenia by age 12 months Predisposition to infection due to functional Asplenia Prophylactic penicillin significantly reduces death from overwhelming infections |
pneumoccocal sepsis/meningitis
|
|
leading cause of death in children & adults over age 5
Clinical presentation of pneumonia and pulmonary infarct may be indistinguishable Causes: pulmonary infection S.aureus, S.pneumoniae, chlamydia, mycoplasma, VOC of pulmonary vessels, fat embolism secondary to marrow infarction, RSV |
Acute Chest Syndrome - Is a potentially fatal complication of SCD
Pathophysiology: Acute chest syndrome is thought to be in situ sickling within the lung producing pain and temporary pulmonary dysfunction |
|
Characterized by:
Chest pain, fever, pulmonary infiltrates & respiratory distress Can be rapidly progressing Antibiotics and oxygen are essentials of therapy Transfusions beneficial in hypoxemic patients |
Acute Chest Syndrome
|
|
How do you treat sickle cell disease?
|
Transfusion in Sickle Cell Disease
Used to increase the oxygen carrying capacity of blood & decrease the proportion of sickled red cells which will improve the microvasculature perfusion of tissues Each 3 cc/kg of PRBC will raise the Hb by 1 gm and decrease the Hgb S by 10% Goal is to stop sickling by raising Hb and decreasing amount of Hgb S |
|
Indications for transfusion in SCD
EPISODIC/ACUTE Management of Severe Anemia/Sudden Acute Illness: |
Acute splenic sequestration
Aplastic crisis Stroke Hyperhemolysis associated with infection and acute chest syndrome |
|
Indications for transfusion in SCD
CHRONIC/PROPHYLACTIC |
Primary Prevention of Stroke
Prevention Of Stroke Recurrence Treatment of Chronic Debilitating Pain Pulmonary Hypertension Chronic Renal Failure Chronic Heart Failure Leg ulcers Priapism |
|
Only known cure for SCD
|
STEM CELL TRANSPLANT
|
|
Drug therapies that change the structure of the red blood cell
Reduce sickling Increase hemoglobin |
RED BLOOD CELL MODIFIERS
Hydroxyurea, Decitabine, ICA-17043, Butyrate |
|
The only drug currently approved by the FDA for the treatment of SCD is ?
|
Hydroxyurea
|
|
increases the production of Hb F, which retards gelation and sickling.
|
Hydroxyurea
|
|
is a group of disorders characterized by a malfunction of the immune system that produces autoantibodies, which attack red blood cells as if they were substances foreign to the body.
|
Autoimmune hemolytic anemia
|
|
Autoimmune hemolytic anemia may be seen in association with?
|
systemic lupus erythematosus (SLE)
chronic lymphocytic leukemia (CLL) lymphomas |
|
The hallmark of this disease is a positive Coomb’s test
|
Auto-Immune Hemolytic Anemias
Warm and Cold |
|
react with RBCs best at 37° and typically do not agglutinate red cells
|
warm antibodies
|
|
typically react best at <32° and do cause RBC agglutination
|
cold antibodies
|
|
Usually IgG antibodies
Fix complement only to level of C3, if at all Immunoglobulin binding occurs at all temps Fc receptors/C3b recognized by macrophages Hemolysis primarily extravascular 70% associated with other illnesses Responsive to steroids/splenectomy |
Warm type autoimmune hemolysis
|
|
What are the laboratory features of warm type autoimmune hemolysis?
|
Splenomegaly, jaundice usually present.
• Depending on degree of anemia and rate of fall in hemoglobin, patients can have VERY symptomatic anemia |
|
What are the laboratory results for warm type autoimmune hemolysis?
|
– ↑reticulocytes, ↑ bili, ↑ LDH,
– positive Coomb’s test - both direct and indirect. – SPHEROCYTES are seen on the peripheral smear. |
|
Looks for immunoglobulin &/or complement on surface of red blood cell (normally neither found on RBC surface)
Coombs reagent - combination of anti-human immunoglobulin & anti-human complement Mixed with patient’s red cells; if immunoglobulin or complement are on surface, Coombs reagent will link cells together and cause agglutination of RBCs |
Coomb's Test
|
|
How do you treat warm type autoimmune hemolysis?
|
Patients may require red cell transfusions, if they are symptomatic with their anemia
Immunosuppression is the mainstay of therapy |
|
• First line is corticosteroids
• If steroids fail to work, or if patient relapses after steroid taper, splenectomy may be necessary IVIg (intravenous IgG) can be used as adjunctive therapy • Immunosuppressives such as cyclophosphamide or azathioprine may be required as third third-line therapy Rituximab (anti-CD20 monoclonal antibody) has been used successfully |
Warm-Antibody Hemolytic Anemias
Immunosuppressive Treatment |
|
Most commonly IgM mediated
Antibodies bind best at 30º or lower Fix entire complement cascade Leads to formation of membrane attack complex, which leads to RBC lysis in vasculature 90% associated with other illnesses Poorly responsive to steroids, splenectomy; responsive to plasmapheresis |
AUTOIMMUNE HEMOLYSIS Cold Type
|
|
Cold agglutinin disease is associated with?
|
Lymphoma
Mycoplasma pneumonia Infectious mononucleosis |
|
Laboratory findings in cold agglutinin?
|
RBC polychromasia
Increased unconjugated bilirubin Decreased haptoglobin Hemoglobinuria Less spherocytosis In many cases agglutination of RBCs is seen on peripheral blood smears (room temperature). C3 is found only on the RBC surface by the DAT. |
|
Occurs when certain drugs interact with the red blood cell membrane, causing the cell to become antigenic.
Alpha-Methyl dopa type: levodopa, methyldopa. Hapten type: Penicillins, cephalosporins. Quinidine type: quinidine. Others: mefenamic acid, salicylic acid, sulfonamides, Thiazide diuretics, antazoline, chlorpromazine, isoniazid, streptomycin, ibuprofen |
Drug induced hemolytic anemia
|
|
Drug-induced hemolytic anemia is most often associated with
|
G6PD deficiency
|
|
Drug binds to & reacts with red cell surface proteins
Antibodies recognize altered protein, ± drug, as foreign Antibodies bind to altered protein & initiate process leading to hemolysis |
Drug induced hemolytic anemia
|
|
• Arsenic - especially arsine gas
• Lead - produces some shortening of RBC lifespan, but anemia mainly due to defect in heme synthesis. • Copper - deliberate ingestion, accumulation of toxic amounts from dialysis fluid exposed to copper pipes, and Wilson’s disease. • Insect, spider (esp brown recluse), snake venoms • Heat/burns |
Hemolysis Associated with
Chemical and Physical Agents |
|
“The great impersonator”
because of the variety of symptoms observed during the initial manifestation and course |
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Paroxysmal Nocturnal Hemoglobinuria (PNH)
3 types of symptoms including: |
(1) an acquired intracorpuscular hemolytic anemia due to the abnormal susceptibility of the RBC membrane to the hemolytic activity of complement
(2) thromboses in large vessels, such as hepatic, abdominal, cerebral, and subdermal veins (3) a deficiency in hematopoiesis that may be mild or severe such as pancytopenia in an aplastic anemia state |
|
Acquired Clonal cell disorder ( remember Aplastic Anemia?)
Ongoing Intra- & Extravascular hemolysis; classically at night (can occur throughout the day) Testing Elevated LDH, The white blood cell count and platelet count may be decreased. A decreased leukocyte alkaline phosphatase Flow cytometric assays may confirm the diagnosis by demonstrating the absence of CD59 (a complement-regulating protein) |
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
PNH may have three components, they are?
|
intravascular hemolysis
inadequate erythropoiesis superimposed iron deficiency (massive iron loss through hemoglobinuria) |
|
How do you treat PNH?
|
Iron replacement is indicated for treatment of iron deficiency
Increased rate of erythropoiesis = give 5 mg/d of folic acid orally Prednisone is effective in decreasing hemolysis (some patients can be managed effectively with alternate-day steroids) In severe cases allogeneic bone marrow transplantation has been used to treat the disorder. |